Frankfurt am Main, Germany

Nino Meyer

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 8.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Nino Meyer: Innovator in Pharmaceutical Composition

Introduction

Nino Meyer is a prominent inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions aimed at treating metabolic disorders.

Latest Patents

Meyer holds four patents, with his latest inventions focusing on liquid pharmaceutical compositions. One of his notable patents involves a liquid pharmaceutical composition that includes a peptide as an active ingredient. This composition is designed for medical use in humans, specifically targeting disorders related to metabolic syndrome, diabetes, and obesity, as well as aiding in the reduction of excess food intake. Another significant patent pertains to conjugates that comprise a GLP-1/Glucagon dual agonist, a linker, and hyaluronic acid. This invention is aimed at creating pharmaceutical compositions that can be used as medicaments for treating or preventing diseases that can be addressed by GLP-1/Glucagon receptor agonists.

Career Highlights

Nino Meyer is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on innovative solutions in the pharmaceutical industry, contributing to advancements in medical treatments.

Collaborations

Meyer has collaborated with notable colleagues, including Dieter Kadereit and Michael Wagner. These collaborations have further enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Nino Meyer is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of metabolic disorders. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…